Immunohistochemistry was used to detect the protein expression of ASAP3, NOTCH3, and their relationship with clinicopathological features in all cohorts in order to study the potential function of ASAP3 and NOTCH3 in the progression of adult glioma (Figure 7). This evidence concerns the gene ASAP3 and central nervous system cancer.